Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC
Clinical trial NCT05400993 · UNKNOWN
Trial details
- NCT number
- NCT05400993
- Sponsor
- Shengjing Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2023-05-23
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.